LEUVEN, Belgium, Nov. 20, 2013 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels:TIG) today announces that on November 19, 2013, after the market closed, it has raised EUR 12 million through a private placement of 34.188.034 new ordinary shares with Gri-Cel S.A., a fully-owned subsidiary of global healthcare company Grifols S.A., at an issue price of EUR 0.351 per new share. The issue price is at least equal to the average closing price of TiGenix’ share on NYSE Euronext Brussels over the 30 day period preceding the date on which issuance of the new shares commenced (i.e. 19 November 2013).
Help employers find you! Check out all the jobs and post your resume.
